Yigal Nochomovitz
Stock Analyst at Citi
(3.97)
# 1,797
Out of 5,074 analysts
819
Total ratings
42.5%
Success rate
5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Reiterated: Buy | $45 → $50 | $19.36 | +158.26% | 32 | Oct 21, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $17 → $4 | $0.4281 | +834.36% | 6 | Oct 20, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $466 | $382.27 | +21.90% | 9 | Oct 19, 2026 | |
| ZLAB Zai Lab | Reiterated: Buy | $45 | $22.04 | +104.17% | 29 | Oct 19, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $386 → $416 | $320.13 | +29.95% | 13 | Oct 16, 2026 | |
| AAPG Ascentage Pharma Group International | Initiated Coverage: Buy | $46 | $14.92 | +208.31% | 1 | Oct 15, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $7 | $0.585 | +1,096.58% | 21 | Oct 14, 2026 | |
| ATTO Attovia Therapeutics | Reiterated: Buy | $30 | $14.50 | +106.90% | 3 | Oct 13, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $160 → $184 | $83.10 | +121.42% | 5 | Oct 13, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $57 | $13.57 | +320.04% | 20 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $28.27 | +69.79% | 14 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $20 | $19.20 | +4.17% | 16 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.82 | +68.11% | 6 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $43 | $15.55 | +176.53% | 23 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $39 | $28.44 | +37.13% | 36 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $13 | $18.18 | -28.49% | 14 | Sep 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $33 | $20.31 | +62.48% | 10 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $10.73 | +86.39% | 22 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $397 | $307.82 | +28.97% | 6 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $32 | $15.95 | +100.63% | 33 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $7.02 | +740.46% | 16 | Sep 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $36.12 | +79.96% | 20 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.1 | $1.49 | +108.05% | 34 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.19 | +126.17% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $12.05 | +74.27% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $49.99 | +76.04% | 27 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 → $253 | $143.29 | +76.57% | 12 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $0.56 | +1,328.57% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $3.25 | +207.69% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.60 | +221.43% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.20 | +243.75% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $7.72 | +172.02% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $83 | $48.86 | +69.87% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $85 | $52.43 | +62.12% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $8.38 | +210.26% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $13.63 | +17.39% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $12.90 | -30.23% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $28.20 | +48.94% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.43 | n/a | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.33 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $11 | $0.9501 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.05 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $0.024 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $3.63 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $1.2 | $2.37 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.09 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.6453 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $35 → $10 | $9.43 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8 | $1.50 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.4 → $0.25 | $13.94 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $63.04 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $2 | $0.96 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €1.30 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $41.93 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $11.26 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.00 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $0.5622 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.000001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.06 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $0.1992 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $6.61 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $0.5461 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.01 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.35 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,417.00 | n/a | 3 | Nov 21, 2014 |
Arcus Biosciences
Oct 21, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $19.36
Upside: +158.26%
EyePoint
Oct 20, 2026
Reiterated: Buy
Price Target: $17 → $4
Current: $0.4281
Upside: +834.36%
BeOne Medicines AG
Oct 19, 2026
Reiterated: Buy
Price Target: $466
Current: $382.27
Upside: +21.90%
Zai Lab
Oct 19, 2026
Reiterated: Buy
Price Target: $45
Current: $22.04
Upside: +104.17%
Krystal Biotech
Oct 16, 2026
Reiterated: Buy
Price Target: $386 → $416
Current: $320.13
Upside: +29.95%
Ascentage Pharma Group International
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $14.92
Upside: +208.31%
Biomea Fusion
Oct 14, 2026
Reiterated: Buy
Price Target: $7
Current: $0.585
Upside: +1,096.58%
Attovia Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $30
Current: $14.50
Upside: +106.90%
Mirum Pharmaceuticals
Oct 13, 2026
Reiterated: Buy
Price Target: $160 → $184
Current: $83.10
Upside: +121.42%
Syndax Pharmaceuticals
Oct 13, 2026
Reiterated: Buy
Price Target: $57
Current: $13.57
Upside: +320.04%
Oct 12, 2026
Reiterated: Buy
Price Target: $48
Current: $28.27
Upside: +69.79%
Oct 7, 2026
Reiterated: Buy
Price Target: $40 → $20
Current: $19.20
Upside: +4.17%
Oct 7, 2026
Reiterated: Buy
Price Target: $35
Current: $20.82
Upside: +68.11%
Sep 30, 2026
Reiterated: Buy
Price Target: $40 → $43
Current: $15.55
Upside: +176.53%
Sep 29, 2026
Reiterated: Buy
Price Target: $38 → $39
Current: $28.44
Upside: +37.13%
Sep 27, 2026
Reiterated: Sell
Price Target: $13
Current: $18.18
Upside: -28.49%
Sep 25, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $20.31
Upside: +62.48%
Sep 24, 2026
Upgraded: Buy
Price Target: $8 → $20
Current: $10.73
Upside: +86.39%
Sep 23, 2026
Reiterated: Buy
Price Target: $390 → $397
Current: $307.82
Upside: +28.97%
Sep 18, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $15.95
Upside: +100.63%
Sep 13, 2026
Reiterated: Buy
Price Target: $59
Current: $7.02
Upside: +740.46%
Sep 10, 2026
Reiterated: Buy
Price Target: $65
Current: $36.12
Upside: +79.96%
Sep 10, 2026
Reiterated: Buy
Price Target: $3.1
Current: $1.49
Upside: +108.05%
Sep 10, 2026
Reiterated: Buy
Price Target: $14
Current: $6.19
Upside: +126.17%
Sep 9, 2026
Reiterated: Buy
Price Target: $21
Current: $12.05
Upside: +74.27%
Sep 4, 2026
Reiterated: Buy
Price Target: $88
Current: $49.99
Upside: +76.04%
Sep 4, 2026
Reiterated: Buy
Price Target: $249 → $253
Current: $143.29
Upside: +76.57%
Aug 13, 2026
Rated: Buy
Price Target: $8
Current: $0.56
Upside: +1,328.57%
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $10
Current: $3.25
Upside: +207.69%
Aug 12, 2026
Reiterated: Buy
Price Target: $18
Current: $5.60
Upside: +221.43%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $11
Current: $3.20
Upside: +243.75%
Aug 10, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $7.72
Upside: +172.02%
Aug 6, 2026
Reiterated: Buy
Price Target: $81 → $83
Current: $48.86
Upside: +69.87%
Aug 6, 2026
Reiterated: Buy
Price Target: $70 → $85
Current: $52.43
Upside: +62.12%
Jun 30, 2026
Reiterated: Buy
Price Target: $26
Current: $8.38
Upside: +210.26%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $13.63
Upside: +17.39%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $12.90
Upside: -30.23%
Mar 9, 2026
Reiterated: Buy
Price Target: $42
Current: $28.20
Upside: +48.94%
Sep 3, 2025
Reiterated: Buy
Price Target: $10
Current: $1.43
Upside: n/a
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.33
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $16 → $11
Current: $0.9501
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.05
Upside: n/a
Sep 12, 2024
Reiterated: Buy
Price Target: $12 → $10
Current: $0.024
Upside: n/a
Aug 15, 2024
Reiterated: Buy
Price Target: $16 → $14
Current: $3.63
Upside: n/a
Jun 17, 2024
Reiterated: Hold
Price Target: $3.5 → $1.2
Current: $2.37
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $10
Current: $2.09
Upside: n/a
Dec 4, 2023
Reiterated: Buy
Price Target: $8
Current: $0.6453
Upside: n/a
Nov 22, 2023
Reiterated: Sell
Price Target: $35 → $10
Current: $9.43
Upside: n/a
Sep 18, 2023
Reiterated: Buy
Price Target: $12 → $8
Current: $1.50
Upside: n/a
Aug 29, 2023
Reiterated: Hold
Price Target: $0.4 → $0.25
Current: $13.94
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $63.04
Upside: n/a
Nov 28, 2022
Reiterated: Buy
Price Target: $5 → $2
Current: $0.96
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: €12.00
Current: €1.30
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $41.93
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $11.26
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.00
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $0.5622
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $10.06
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $32
Current: $0.1992
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $6.61
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $0.5461
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $1.01
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $11.35
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,417.00
Upside: n/a